Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial

Ajar Kochar, Anne Hellkamp, Yuliya Lokhnygina, William Jones, Richard Becker, Scott Berkowitz, Guenter Breithardt, Keith Fox, Jonathan Halperin, Graeme Hankey, Kenneth Mahaffey, Christopher Nessel, Daniel Singer, Jonathan Piccini, Manesh Patel

Research output: Contribution to journalAbstract/Meeting Abstract

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)737-737
Number of pages1
JournalJournal of the American College of Cardiology
Volume67
Issue number13
DOIs
Publication statusPublished - 5 Apr 2016
Event65th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC) - Chicago, Israel
Duration: 2 Apr 20164 Apr 2016

Cite this

Kochar, A., Hellkamp, A., Lokhnygina, Y., Jones, W., Becker, R., Berkowitz, S., Breithardt, G., Fox, K., Halperin, J., Hankey, G., Mahaffey, K., Nessel, C., Singer, D., Piccini, J., & Patel, M. (2016). Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial. Journal of the American College of Cardiology, 67(13), 737-737. https://doi.org/10.1016/S0735-1097(16)30738-0